UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.___________)*
DIATIDE, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $.001 PER SHARE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
252842-10-9
------------------------------------------
(CUSIP Number)
JANUARY 19, 1999
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 15
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 252842-10-9
- ----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Alta Partners
- ----------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ----------------------------------------------------------------------------------------------------------------
3. SEC Use Only.
- ----------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization California
- ----------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 825,309
Shares Bene- ----------------------------------------------------------------------------------------------
ficially Owned 6. Shared Voting Power 0
by Each ----------------------------------------------------------------------------------------------
Reporting 7. Sole Dispositive Power 825,309
Person With: ----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 0
- ----------------------------------------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 825,309
10. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions).............
11. Percent of Class Represented by Amount in Row (11) 7.2%
- ----------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions) IA, CO
- ----------------------------------------------------------------------------------------------------------------
</TABLE>
Page 2 of 15
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 252842-10-9
- ----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Alta BioPharma Partners, L.P.
- ----------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ----------------------------------------------------------------------------------------------------------------
3. SEC Use Only.
- ----------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
- ----------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 795,332
Shares Bene- ----------------------------------------------------------------------------------------------
ficially Owned 6. Shared Voting Power 0
by Each ----------------------------------------------------------------------------------------------
Reporting 7. Sole Dispositive Power 795,332
Person With: ----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 0
- ----------------------------------------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 795,332
10. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)...............
11. Percent of Class Represented by Amount in Row (11) 7.0%
- ----------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions) PN
- ----------------------------------------------------------------------------------------------------------------
</TABLE>
Page 3 of 15
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 252842-10-9
- ----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Alta Embarcadero BioPharma Partners, LLC
- ----------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ----------------------------------------------------------------------------------------------------------------
3. SEC Use Only.
- ----------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
- ----------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 29,977
Shares Bene- ----------------------------------------------------------------------------------------------
ficially Owned 6. Shared Voting Power 0
by Each ----------------------------------------------------------------------------------------------
Reporting 7. Sole Dispositive Power 29,977
Person With: ----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 0
- ----------------------------------------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 29,977
10. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions).............
11. Percent of Class Represented by Amount in Row (11) 0.3%
- ----------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions) CO
- ----------------------------------------------------------------------------------------------------------------
</TABLE>
Page 4 of 15
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 252842-10-9
- ----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Alta BioPharma Management, LLC
- ----------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ----------------------------------------------------------------------------------------------------------------
3. SEC Use Only.
- ----------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
- ----------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 825,309
Shares Bene- ----------------------------------------------------------------------------------------------
ficially Owned 6. Shared Voting Power 0
by Each ----------------------------------------------------------------------------------------------
Reporting 7. Sole Dispositive Power 825,309
Person With: ----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 0
- ----------------------------------------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 825,309
10. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions).............
11. Percent of Class Represented by Amount in Row (11) 7.2%
- ----------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions) CO
- ----------------------------------------------------------------------------------------------------------------
</TABLE>
Page 5 of 15
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 252842-10-9
- ----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Jean Deleage
- ----------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ----------------------------------------------------------------------------------------------------------------
3. SEC Use Only.
- ----------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization USA
- ----------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 46,472
Shares Bene- ----------------------------------------------------------------------------------------------
ficially Owned 6. Shared Voting Power 825,309
by Each ----------------------------------------------------------------------------------------------
Reporting 7. Sole Dispositive Power 46,472
Person With: ----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 825,309
- ----------------------------------------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 871,781
10. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions).............
11. Percent of Class Represented by Amount in Row (11) 7.6%
- ----------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions) IN
- ----------------------------------------------------------------------------------------------------------------
</TABLE>
Page 6 of 15
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 252842-10-9
- ----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Garrett Gruener
- ----------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ----------------------------------------------------------------------------------------------------------------
3. SEC Use Only.
- ----------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization USA
- ----------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 0
Shares Bene- ----------------------------------------------------------------------------------------------
ficially Owned 6. Shared Voting Power 825,309
by Each ----------------------------------------------------------------------------------------------
Reporting 7. Sole Dispositive Power 0
Person With: ----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 825,309
9. Aggregate Amount Beneficially Owned by Each Reporting Person 825,309
10. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions).............
11. Percent of Class Represented by Amount in Row (11) 7.2%
- ----------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions) IN
- ----------------------------------------------------------------------------------------------------------------
</TABLE>
Page 7 of 15
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 252842-10-9
- ----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Daniel Janney
- ----------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ----------------------------------------------------------------------------------------------------------------
3. SEC Use Only.
- ----------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization USA
- ----------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 0
Shares Bene- ----------------------------------------------------------------------------------------------
ficially Owned 6. Shared Voting Power 825,309
by Each ----------------------------------------------------------------------------------------------
Reporting 7. Sole Dispositive Power 0
Person With: ----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 825,309
- ----------------------------------------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 825,309
10. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions).............
11. Percent of Class Represented by Amount in Row (11) 7.2%
- ----------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions) IN .
- ----------------------------------------------------------------------------------------------------------------
</TABLE>
Page 8 of 15
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 252842-10-9
- ----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Alix Marduel
- ----------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ----------------------------------------------------------------------------------------------------------------
3. SEC Use Only.
- ----------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization USA
- ----------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 0
Shares Bene- ----------------------------------------------------------------------------------------------
ficially Owned 6. Shared Voting Power 825,309
by Each ----------------------------------------------------------------------------------------------
Reporting 7. Sole Dispositive Power 0
Person With: ----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 825,309
- ----------------------------------------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 825,309
10. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions).............
11. Percent of Class Represented by Amount in Row (11) 7.2%
- ----------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions) IN
- ----------------------------------------------------------------------------------------------------------------
</TABLE>
Page 9 of 15
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 252842-10-9
- ----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Guy Nohra
- ----------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ----------------------------------------------------------------------------------------------------------------
3. SEC Use Only.
- ----------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization USA
- ----------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 0
Shares Bene- ----------------------------------------------------------------------------------------------
ficially Owned 6. Shared Voting Power 825,309
by Each ----------------------------------------------------------------------------------------------
Reporting 7. Sole Dispositive Power 0
Person With: ----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 825,309
- ----------------------------------------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 825,309
10. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions).............
11. Percent of Class Represented by Amount in Row (11) 7.2%
- ----------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions) IN
- ----------------------------------------------------------------------------------------------------------------
</TABLE>
Page 10 of 15
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 252842-10-9
- ----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Marino Polestra
- ----------------------------------------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
- ----------------------------------------------------------------------------------------------------------------
3. SEC Use Only.
- ----------------------------------------------------------------------------------------------------------------
4. Citizenship or Place of Organization USA
- ----------------------------------------------------------------------------------------------------------------
Number of 5. Sole Voting Power 0
Shares Bene- ----------------------------------------------------------------------------------------------
ficially Owned 6. Shared Voting Power 825,309
by Each ----------------------------------------------------------------------------------------------
Reporting 7. Sole Dispositive Power 0
Person With: ----------------------------------------------------------------------------------------------
8. Shared Dispositive Power 825,309
- ----------------------------------------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person 825,309
10. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions).............
11. Percent of Class Represented by Amount in Row (11) 7.2%
- ----------------------------------------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions) IN
- ----------------------------------------------------------------------------------------------------------------
</TABLE>
Page 11 of 15
<PAGE>
Item 1.
(a) Name of Issuer
DIATIDE, INC.
(b) Address of Issuer's Principal Executive Offices
Nine Delta Drive
Londonderry, New Hampshire 03053
Item 2.
(a) Name of Person Filing
Alta Partners; Alta BioPharma Partners, L.P.; Alta Embarcadero
BioPharma Partners, LLC; Alta BioPharma Management, LLC; Jean
Deleage; Garrett Gruener; Daniel Janney; Alix Marduel; Guy Nohra;
Marino Polestra
(b) Address of Principal Business Office or, if none, Residence
The business address of all persons jointly filing this Schedule
13G is:
One Embarcadero Center, Suite 4050
San Francisco, California 94111
(c) Citizenship
See Item 4. of cover pages
(d) Title of Class of Securities
Common Stock, par value $.001 per share
(e) CUSIP Number
252842-10-9
Item 3. If this statement is filed pursuant to ss.ss.240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Act (15
U.S.C. 78o);.
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c);
(d) [ ] Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e) [ ] An investment advisor in accordance with
ss.240.13d-1(b)(1)(ii)(E);
Page 12 of 15
<PAGE>
(f) [ ] An employee benefit plan or endowment fund in accordance with
ss.240.13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance with
ss.240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings association as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(J).
Item 4. Ownership
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 871,781: See Item 9 of cover pages for
details as to each person filing this Schedule 13G.
(b) Percent of class: 7.6%: See Item 11 of cover pages for details as to
each person filing this Schedule 13G.
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: See Item 5 of cover
pages for details as to each person filing this Schedule 13G.
(ii) Shared power to vote or to direct the vote: See Item 6 of
cover pages for details as to each person filing this Schedule
13G.
(iii) Sole power to dispose or to direct the disposition of: See
Item 7 of cover pages for details as to each person filing
this Schedule 13G.
(iv) Shared power to dispose or to direct the disposition of: See
Item 8 of cover pages for details as to each person filing
this Schedule 13G.
Instruction. For computations regarding securities which represent a
right to acquire an underlying security see ss.240.13d-3(d)(1).
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following. [ ]
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company.
This Statement is filed jointly by Alta BioPharma Partners, L.P. ("Alta
BioPharma") and Alta Embarcadero BioPharma Partners, LLC ("Embarcadero LLC"), by
virtue of their direct beneficial ownership of 825,309 shares of Series B
Convertible Preferred Stock that are currently convertible into 825,309 shares
of the Common Stock of Diatide, Inc. reported hereby (the "Shares"); by Alta
BioPharma Management Partners, LLC ("Alta Management"), by virtue of being the
sole general partner of Alta BioPharma; and by Alta Partners ("Alta Partners"),
by virtue of being the management advisory company of these entities. Jean
Deleage, Garrett Gruener, Dan Janney, Alix Marduel, Guy Nohra and Marino
Polestra are the managing directors of Alta Management and officers of Alta
Partners (the "Partners"). By
Page 13 of 15
<PAGE>
virtue of the relationships described above and their roles with Alta Partners,
each of the Partners may be deemed to control Alta Partners and Alta Management,
and, therefore, may be deemed to possess indirect beneficial ownership of the
Shares held by each entity. However, none of the Partners, acting alone, has
voting or investment power with respect to the Shares directly beneficially held
by the entities and, as a result, the Partners disclaim beneficial ownership of
the Shares directly beneficially owned by each entity, except to the extent of
their pecuniary interest in each entity. Jean Deleage individually holds 46,472
shares of Diatide Inc.'s Common Stock. Embarcadero LLC is a side company that
makes all investments pro rata to the capital of Alta BioPharma with all
allocations made to its members based on paid-in capital. Certain of the
Partners are members of Embarcadero LLC and certain members of Embarcadero LLC
are affiliates of Alta Partners.
Item 8. Identification and Classification of Members of the Group
Not Applicable
Item 9. Notice of Dissolution of Group
Not Applicable
Item 10. Certification
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: January 27, 1999
ALTA PARTNERS ALTA BIOPHARMA PARTNERS, L.P.
By: Alta BioPharma
Management, LLC,
Its General Partner
By: /s/ Eileen McCarthy By: /s/ Eileen McCarthy
- ----------------------------------- ------------------------------
Eileen McCarthy, Vice President Eileen McCarthy, Member
ALTA EMBARCADERO BIOPHARMA PARTNERS, ALTA BIOPHARMA MANAGEMENT, LLC
LLC
By: /s/ Eileen McCarthy By: /s/ Eileen McCarthy
- ----------------------------------- ------------------------------
Eileen McCarthy, Member Eileen McCarthy, Member
/s/ Jean Deleage /s/ Garrett Gruener
- ----------------------------------- ------------------------------
Jean Deleage Garrett Gruener
/s/ Daniel Janney /s/ Alix Marduel
- ----------------------------------- ------------------------------
Daniel Janney Alix Marduel
/s/ Guy Nohra /s/ Marino Polestra
- ----------------------------------- ------------------------------
Guy Nohra Marino Polestra
Page 14 of 15
<PAGE>
EXHIBIT A
Joint Filing Statement
We, the undersigned, hereby express our agreement that the attached
Schedule 13G is filed on behalf of each of us.
Date: January 27, 1999
ALTA PARTNERS ALTA BIOPHARMA PARTNERS, L.P.
By: Alta BioPharma
Management, LLC,
Its General Partner
By: /s/ Eileen McCarthy By: /s/ Eileen McCarthy
- ----------------------------------- ------------------------------
Eileen McCarthy, Vice President Eileen McCarthy, Member
ALTA EMBARCADERO BIOPHARMA PARTNERS, ALTA BIOPHARMA MANAGEMENT, LLC
LLC
By: /s/ Eileen McCarthy By: /s/ Eileen McCarthy
- ----------------------------------- ------------------------------
Eileen McCarthy, Member Eileen McCarthy, Member
/s/ Jean Deleage /s/ Garrett Gruener
- ----------------------------------- ------------------------------
Jean Deleage Garrett Gruener
/s/ Daniel Janney /s/ Alix Marduel
- ----------------------------------- ------------------------------
Daniel Janney Alix Marduel
/s/ Guy Nohra /s/ Marino Polestra
- ----------------------------------- ------------------------------
Guy Nohra Marino Polestra
Page 15 of 15
